Skip to main content

AZB & Partners tops League Table for Legal Advisors to M&A deals in 2022

By
AZB & Partners (AZB) topped the Venture Intelligence League Table for Legal Advisor to M&A Transactions during 2022. AZB advised 81 M&A deals worth $73.8 Billion. They were followed by Argus Partners ($44.56 Billion across 9 deals) and Wadia Ghandy ($40.02 Billion across 5 deals) in the second and third spots, respectively. Cravath, Swaine & Moore ($40 Billion across 1 deal) took the fourth spot, with Cyril Amarchand Mangaldas (CAM) ($34.6 Billion across 90 deals) completing the top five.





Among the largest M&A deals during 2022, AZB, Argus Partners, Cravath, Swaine & Moore and Wadia Ghandy advised the $40 Billion merger of HDFC Limited with HDFC Bank.  AZB and CAM advised $10.5 Billion Adani Group's acquisition of  Switzerland-based Holcim’s entire stake in its two Indian cement companies, Ambuja Cements Ltd and ACC Ltd . Saraf and Partners, SAM, K Law, Baker Mckenzie, and Goodwin Procter advised the $3.3 Billion acquisition of Viatris’ biosimilars business by Biocon Biologics (a subsidiary of publicly listed Biocon).

The Venture Intelligence League Tables, the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE and M&A transactions advised by Financial and Legal Advisory firms.

Among foreign firms, Cravath, Swaine & MooreBaker advising the HDFC-HDFC Bank deal worth $40 Billion. Baker McKenzie and Goodwin Procter followed the next spot having advised 1 deal worth $3.3 Billion. They were followed by Clifford Chance and Linklaters with 1 deal worth $1.6 Billion.




The full league table can be viewed online at https://www.ventureintelligence.com/leagues.php

By Deal Volume

CAM took the top spot with 90 deals, followed by Khaitan & Co. with 89 deals. AZB (81 deals), SAM (79 deals), and Trilegal (68 deals).




By Industry

Under the BFSI industry (by value), AZB topped the table by advising 10 deals worth $42 Billion, followed by Argus Partners ($40.1 Billion across 3 deals). Cravath, Swaine & Moore ($40 Billion across 1 deal) and Wadia Ghandy ($40 Billion across 2 deals) took the third spot. CAM took the fourth position, advising 8 deals across $4 Billion.

AZB topped the table under Manufacturing industry, having advised 13 deals worth $12.7 Billion, followed by CAM (7 deals worth $11.1 Billion) and Khaitan & Co. (19 deals worth $1.95 Billion).

Under the Healthcare industry, SAM topped the table by advising 5 deals worth $4.9 Billion. Saraf and Partners took the second spot, advising 1 deal worth $3.33 Billion. 

Under the Media & Entertainment industry (by value), AZB ($4.9 Billion) topped the table followed by SAM with deals worth $4.4 Billion. Argus Partners and Anagram Partners took the third position by advising deal worth $3.2 Billion.

The full league table can be viewed online at https://www.ventureintelligence.com/leagues.php

To showcase your firms' transactions in the 2023 League Tables, contact Vanathi at
deals@ventureintelligence.com.

About Venture Intelligence

Venture Intelligence is India's longest-serving provider of data and analysis on Private Company Financials, Transactions (private equity, venture capital, and M&A) & their Valuations in India.
Labels:

Popular posts from this blog

EY Tops League Table for Transaction Advisors to M&A deals in 24

By
Moelis & Company & PwC claim the No.2 & No.3 slots Ernst & Young  (EY) topped the Venture Intelligence League Table for Transaction Advisor to M&A Deals   during 2024, advising 34 deals worth $4.1 Billion. Moelis & Company stood second advising 2 deals worth $3.9 billion. PwC followed with 18 deals worth $3.3 billion. Citi ($2.5 billion across 1 deal) and Advay Capital ($2.3 billion across 1 deal) completed the top five. Among the largest M&A deals in 2024, Citi  advised $2.5 Billion acquisition of the Indian business of American Tower Corporation by Brookfield , Advay Capital and Moelis & Company advised the $2.3 Billion acquisition of Care Hospitals by Aster DM Healthcare . Jefferies & Co., JP Morgan and Moelis & Company advised the $1.6 Billion acquisition of Bharat Serums & Vaccines by Mankind Pharma.  Among the other notable M&A deals in Q4 2024, EY advised the $685 million acquisition of ITD Cementation ...
Read more

Morgan Stanley tops League Table for Transaction Advisors to M&A deals in 2020

By
Morgan Stanley , which advised the $10.1 Billion strategic investment by Facebook and Google into Reliance Industries' telecom arm Jio platforms (among other Private Equity investments in the company), topped the Venture Intelligence League Table for Transaction Advisor to M&A Deals for 2020. Ambit Corporate Finance - which advised 3 deals worth $4.0 Billion, including Brookfield's $3.7 Billion acquisition of Reliance Tower Infrastructure Trust -  took the second spot. JM Financial ($3.7 Billion across 5 deals), Metta Capital ($3.4 Billion across 3 deals) and ICICI Securities ($3.4 Billion across 2 deals) - all of whom (along with Citi) are advisors to the $3.4 Billion acquisition of Future Group's retail related ventures by Reliance Retail, announced in August - completed the top five. The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE and M&A tra...
Read more

Everything you wanted to know (and some things you didn't care to know) about ChrysCapital's Ashish Dhawan

By
New Delhi-based private equity fund ChrysCapital is vastly different from its former avatar, Chrysalis Capital. While Chrysalis began life (in Mumbai) as an venture capital firm focussed on start-up investments, today's ChrysCapital is best know for its late-stage investments (often in already public companies). The fascinating part of this transformation is that one of the fund's original partners - Senior Managing Director Ashish Dhawan - has been firmly in the driver's seat throughout the process. It's a story that needed to be told. As a cover story. Kudos to Business Today for telling it first. Thankfully, unlike the glowing profiles that BT is famous for - including the one featuring infamous stock brocker Harshad Mehta with his Lexus on the cover - this one has a lot of facts. Some well known. And others less so. That ChrysCapital's first fund would have been a disaster but for the pioneering investment in Raman Roy founded BPO firm Spectramind i...
Read more

Why did Sony Entertainment Television's CEO quit?

By
Businessworld has a cover story on the corporate battle that resulted in Kunal Dasgupta, the CEO of Multi Screen Media (formerly Sony Entertainment Television), quitting just a few months before his contract was due to end. Dasgupta’s abrupt exit was the culmination of six years of tension between majority shareholder Sony Pictures Television International (SPTI) that owns 61 per cent of MSM, on one hand, and Atlas Equifinn on the other, which is a consortium of Indian shareholders (Singapore-based Rakesh Aggarwal, World Media Group director Sudesh Iyer, Shemaroo Entertainment Managing Director Raman Maroo, MobiApps Holding’s Jayesh Parekh, B.R. Sule, Sushil Shergil and actor Jackie Shroff ) holding 32 per cent. Capital Japan and some financial institutions own the rest 7 per cent. And of course, the third protagonist is Dasgupta, who walked a tightrope and managed to keep his job for over 14 years despite the fact that neither group of shareholders was too happy with him. Very little...
Read more

VC Interview: Shailendra Singh of Sequoia Capital India

By
In a recent interview to Venture Intelligence, Shailendra Singh discussed some of the firm’s newer investments in the early stage segment including in the online payments space, the progress at a few existing portfolio companies and the active role the firm is playing in helping its portfolio companies scale and succeed in India and globally. Prior to joining the firm in 2006, Singh was a strategy consultant at Bain & Company in New York and before that, an entrepreneur in the digital media industry. Venture Intelligence: How does Sequoia go about identifying potential early stage investments in India? Is there anything different you are doing today than, say, a couple of years back? Shailendra Singh: There is a lot more focus on technology investing and early stage investing. In general, as you might remember a few years ago, we were doing primarily growth investing but in the past 18-odd months, we have had a very strong focus on early stage and that’s continuing. In terms...
Read more